ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare FacilitiesNew Area Decontamination Technology Broadens ASP's Portfolio of Infection Prevention Solutions by Providing Patients with Assurance that Their Hospital Environment is Disinfected New H1N1 Flu Test Available Now - On Display At MEDICA 20092009 H1N1 Flu Test from Quest Diagnostics Now CE Marked For International Distribution under the Simplexa(TM) brand name Hard To Treat Diseases (HTDS) Mellow Hope's H1N1 Influenza A Vaccine Successful Registration in ChileSHENZHEN, China, November 18 - Hard to Treat Diseases (HTDS; www.htdsmedical.com) and its China Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS ConferenceFavorable safety and pharmacokinetic data support further clinical development Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 September 2009KVISTGARD, Denmark, November 11 - Today Bavarian Nordic published the company's third quarterly report U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance ThreatWASHINGTON - Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. During a summit held this week in Washington, D.C., President Obama and Prime Minister Reinfeldt joined forces to address the urgency of the problem and the need for solutions by signing an international agreement that seeks cooperative ways in which the United States and EU countries can help combat the global health crisis. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain ConferenceNOVATO, California - - Proof-of-Concept Data at 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain Rest Of World H1N1 (swine flu) Vaccination MarketOpportunity Analysis of H1N1 (swine flu) Vaccination Market report ( http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html ) assess that H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918). Cambodia: World AIDS Day HIV Campaign, ‘Testing Millions,’ to Again Launch During Cambodia’s National Water FestivalPHNOM PENH, Cambodia - - During Last Year’s ‘One Million Tests’ World AIDS Day 2008 Campaign, AHF/Cambodia CARES and Cambodian Partners Surpassed Country’s 30,000 Testing Goal by Testing 35,034 Roche Introduces New cobas p 630 Instrument and AMPLILINK 3.3 Series Software With CE MarkPLEASANTON, California - - New pre-analytical solution that integrates automated primary tube handling Largest British Fund for Biomedical Research Finances Project on Breakbone Fever in Leuven (K.U.Leuven)LEUVEN, Belgium - - The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the “Centre for Drug Design and Discovery” (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the ‘dengue fever virus’. Dengue or ‘breakbone fever’ is widespread in tropical and subtropical regions. As of yet, there is neither a vaccine nor any form of treatment for this disease. - The findings of the researchers in Leuven will be developed further into medication, in co-operation with the pharmaceutical industry. - The Wellcome Trust is the largest independent fund for biomedical research in the United Kingdom. This is the first time that the fund is financing technology transfer on the European continent. Arab Health 2010: Ansell Showcases Latest Innovations in Hand Protection Solutions Dedicated to Healthcare ProfessionalsBRUSSELS - - Comprehensive Gammex(R) Surgical Range and a Wide Selection of Examination Gloves Offer Optimal Protection and Prevent Infections and Allergies Eazyrecruit to Support Starfish Greathearts through a Five Year PledgeLONDON - Eazyrecruit, the fixed fee resourcing firm, pledged to support Starfish, a leading HIV/AIDS charity in a five year donation deal. Bill & Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious DiseaseARUSHA, Tanzania - - Scientists from Africa and Europe selected for their unconventional projects to accelerate the eradication of malaria, HIV and AIDS, tuberculosis and other infectious diseases Ground-Breaking Innovation: Natural Protection Against Infectious Diseases by Human-Milk-Oligosaccharide FucosyllactoseBONN and RHEINBREITBACH, Germany - Human milk oligosaccharides - an important ingredient in human breast milk - play a central role in protecting infants against infection. An innovative process developed by Jennewein Biotechnologie GmbH allows for the first time ever the production of these scarce sugar molecules for use as an ingredient in baby food and in additional food products. Neopharma Receives Approval From UAE Ministry of Health to Manufacture H1N1 MedicineDUBAI, UAE - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, today announced it has received clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu. HIV Vaccine Study First to Show Some Effectiveness in Preventing HIVROCKVILLE, Maryland - A Phase III clinical trial involving more than 16,000 adult volunteers in Thailand has demonstrated that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection. According to final results released by the trial sponsor, the U.S. Army Surgeon General, the prime boost combination of ALVAC(R) HIV and AIDSVAX(R) B/E lowered the rate of HIV infection by 31.2% compared with placebo. 30th Anniversary Edition of Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases is More Relevant Than EverPHILADELPHIA, Pennsylvania - - Highly Respected Text Addresses New Strains of the Swine (H1N1) and Avian Influenza Viruses. OneDotOneLife.org - Saving the Lives of More Than 2 Million ChildrenPORTO, Portugal - As of today, 23 September 2009, the site will be online www.onedotonelife.org, an innovative project on the Internet which combines social solidarity and digital art. ASP Launches 24-Minute EXPRESS Cycle for the STERRAD(R) 100NX(TM) SystemIRVINE, California - - New Cycle is One of the Fastest on the Market and is Validated to Sterilize da Vinci(R) 3D Endoscopes Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Enhance Efficiency and Scale-up of its Malaria Vaccine Manufacturing ProcessROCKVILLE, Maryland - Sanaria Inc. has received additional support from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in the form of a Phase II Small Business Innovation Research (SBIR) Grant. The award for two years is US$1.99 million. Subject to satisfactory progress by Sanaria, continued funding for a third year will bring the total to nearly US$3 million. This new funding will facilitate efforts to increase the efficiency and scale-up of manufacturing and release processes to the levels required for Phase 3 clinical testing, licensure, and commercial launch of Sanaria(TM) PfSPZ, Sanaria’s attenuated whole parasite malaria sporozoite vaccine. OAG Releases Prototype for Pandemic Disease Planning and ManagementCHICAGO - - Modelling Air Travel Could Prove Critical for Health Organizations and Government Agencies Preparing for the Upcoming Flu Season Home-Spun or Hard Fact?NEWBURY, England - - Fast-Food Family Planning May Contribute to High Levels of Unintended Pregnancies Norovirus Aboard Cruise Ship Marco Polo Rapidly Eradicated by Revolutionary new Vaporisation ProcessLONDON - The cruise ship Marco Polo, whose round-Britain cruise had to be cancelled because hundreds of passengers became ill with the vomiting bug Norovirus, has been totally disinfected by SitexOrbis’ revolutionary infection control fogging service in just 5 hours at the Tilbury docks. NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza VaccinesNES ZIONA, Israel - - Intradermal Delivery of Vaccines can Provide Significant Dose Sparing Urgently Required in the Swine H1N1 Pandemic Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b TrialPALO ALTO, California - - Proof of Concept Study Investigating NS4B-RNA Binding Inhibitor Health Robotics Announces American Joint Venture With i.v.SOFTBOZEN, Italy - Health Robotics today announced that it has embarked in a joint venture with i.v.SOFT in order to market, implement, and support its I.V. Workflow Engine and related software automation modules to hospitals and infusion centers in North America. One of its software modules (OncoCube) has already been installed and is being currently utilized at the University of Colorado Hospital [Denver], in addition to all-digital and totally integrated I.V. installations at La Maddalena Cancer Center in Palermo and Campus Biomedico University General Hospital in Rome. Demand for Private Swine Flu Tests as Government Stops TestingLONDON - - MediChecks.com is the First Company in the UK to Make Available a Swine Flu Test to Individuals and Companies Nationally Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.PORTON DOWN, England - Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). Israel Adds Wyeth’s 7-valent Pneumococcal Conjugate Vaccine (PCV7) to their National Immunisation ProgrammeMAIDENHEAD, England - - Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide Wyeth’s Prevenar 13* Receives First ApprovalCOLLEGEVILLE, Pennsylvania - - Chile Grants First Approval of Prevenar 13 for the Prevention of Pneumococcal Disease in Infants and Children- Sigma-tau Submits Marketing Authorization Application to EMEA for a Novel Anti-MalarialROME - - An Innovative Fixed-Dose Combination Therapy, With a Very Simple Dosing Regimen, for Combating a Disease That Accounts for 250 Million Cases Worldwide Per Year and Causes 880,000 Deaths, Especially of Children Under 5 in Sub-Saharan Africa Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK’s Veterinary Laboratories AgencyPORTON DOWN, England - Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory). /C O R R E C T I O N — Enigma Diagnostics Limited/PORTON DOWN, England - In the news release, “Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK’s Veterinary Laboratories Agency” issued on 30 Jun 2009 13:17 GMT, by Enigma Diagnostics Limited over PR Newswire, we are advised by a representative of the company that a second footnote has been added at the end of the fourth paragraph. The note references the following link: enigmadiagnostics.com/template2.php?page=news.php&m=4 WHO and EFA Call for Global Action on Chronic Respiratory DiseaseROME - Call to Reduce the Four Million Deaths Annually, From a Condition Responsible for More Fatalities Globally Than AIDS[1] |
